PAR Technology (NYSE:PAR – Free Report) had its target price lifted by JPMorgan Chase & Co. from $17.00 to $18.00 in a research note released on Friday,Benzinga reports. The brokerage currently has a neutral rating on the software maker’s stock. A number of other research firms have also recently weighed in on PAR. UBS Group […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Sotera Health (NASDAQ:SHC) Price Target Raised to $18.00 | 0 | 12.25 | 10-08-2026 |
| 2 | Target (NYSE:TGT) Price Target Raised to $157.00 | 0 | 13.85 | 10-08-2026 |
| 3 | Replimune Group (NASDAQ:REPL) Price Target Raised to $20.00 | 0 | 13.83 | 10-08-2026 |
| 4 | Genpact (NYSE:G) Price Target Raised to $45.00 | 0 | 14.26 | 10-08-2026 |
| 5 | TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $72.00 | 0 | 13.04 | 10-08-2026 |
| 6 | Airbnb (NASDAQ:ABNB) Price Target Raised to $170.00 | 0 | 13.46 | 10-08-2026 |
| 7 | Centrus Energy (NYSE:LEU) Price Target Raised to $180.00 | 0 | 13.43 | 10-08-2026 |
| 8 | Royalty Pharma (NASDAQ:RPRX) Price Target Raised to $62.00 | 0 | 13.82 | 10-08-2026 |
| 9 | Insight Enterprises (NASDAQ:NSIT) Price Target Raised to $160.00 | 0 | 14.65 | 10-08-2026 |
| 10 | MKS (NASDAQ:MKSI) Price Target Raised to $380.00 | 0 | 13.85 | 10-08-2026 |